Skip to main content

Women With High-Risk HPV Have Increased Risk for Heart Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 9, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Feb. 9, 2024 -- Women with high-risk human papillomavirus (HR-HPV) infection have an increased risk for cardiovascular disease (CVD), according to a study published online Feb. 7 in the European Heart Journal.

Hae Suk Cheong, M.D., Ph.D., from Kangbuk Samsung Hospital in Seoul, South Korea, and colleagues examined the associations between HR-HPV infection and CVD mortality in a study involving 163,250 CVD-free Korean women (mean age, 40.2 years) who underwent HR-HPV screening and were followed for a median of 8.6 years.

The researchers identified 134 CVD deaths during 1,380,953 person-years of follow-up, with mortality rates of 9.1 and 14.9 per 100,000 person-years for HR-HPV(−) and HR-HPV(+) women, respectively. For women with versus those without HR-HPV infection, the hazard ratios for atherosclerotic CVD (ASCVD), ischemic heart disease, and stroke mortality were 3.91, 3.74, and 5.86, respectively, after adjustment for traditional CVD risk factors and confounders. The association between HR-HPV infection and ASCVD mortality was stronger for women with versus those without obesity (hazard ratios, 4.81 and 2.86, respectively).

"This study highlights the importance of comprehensive care for patients with high-risk HPV. Clinicians should monitor cardiovascular health in patients with high-risk HPV, particularly those with obesity or other risk factors," Cheong said in a statement. "It's important for people with high-risk HPV to be aware of the potential for both heart disease and cervical cancer risks."

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.